| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |